7Baggers
 Published on: 2025-11-13 23:21:08  newser.com Fri, 14 Nov 2025 05:21:08 GMT
 amylyx at guggenheim conference: strategic focus on evexetide  Investing.com Mon, 10 Nov 2025 23:43:45 GMT
 Amylyx Pharmaceuticals Ends PSP Trial of AMX0035  AFTD - The Association for Frontotemporal Degeneration Mon, 10 Nov 2025 22:00:44 GMT
 amylyx price target raised to $18 from $16 at mizuho  TipRanks Mon, 10 Nov 2025 14:10:10 GMT
 amylyx pharmaceuticals stock price target raised to $20 at h.c. wainwright  Investing.com UK Mon, 10 Nov 2025 12:36:00 GMT
 td cowen maintains amylyx pharmaceuticals(amlx.us) with buy rating  富途牛牛 Fri, 07 Nov 2025 16:20:35 GMT
 amylyx price target raised to $20 from $16 at h.c. wainwright  TipRanks Fri, 07 Nov 2025 16:00:57 GMT
 Amylyx Pharmaceuticals Inc (AMLX): A Strategic SWOT Insight  GuruFocus Fri, 07 Nov 2025 06:34:40 GMT
 amylyx pharmaceuticals reports strong q3 2025 results  TipRanks Fri, 07 Nov 2025 05:20:28 GMT
 amylyx narrowed losses and raised cash to power future plans  Finimize Thu, 06 Nov 2025 19:07:34 GMT
 td cowen maintains amylyx pharmaceuticals(amlx.us) with buy rating  富途牛牛 Thu, 06 Nov 2025 17:31:00 GMT
 Notice to Long-Term Shareholders of Amylyx Pharmaceuticals,  GlobeNewswire Thu, 06 Nov 2025 15:28:11 GMT
 amylyx pharmaceuticals shares lower after q3 results  MarketScreener Thu, 06 Nov 2025 15:26:35 GMT
 amylyx pharmaceuticals q3 2025 earnings preview  MSN Thu, 06 Nov 2025 14:16:15 GMT
 amylyx reports q3 eps (37c), consensus (43c)  TipRanks Thu, 06 Nov 2025 13:48:59 GMT
 Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results  Business Wire Thu, 06 Nov 2025 12:00:00 GMT
 Amylyx Pharmaceuticals Reports Strong Q3 2025 Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Amylyx Pharmaceuticals, Inc. SEC 10-Q Report  TradingView Thu, 06 Nov 2025 08:00:00 GMT
 Vanguard Group Inc's Strategic Acquisition of Amylyx Pharmaceuti  GuruFocus Thu, 06 Nov 2025 01:30:00 GMT
 amylyx pharmaceuticals q3 2025 earnings preview  MSN Wed, 05 Nov 2025 17:31:52 GMT
 Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences  Business Wire Mon, 03 Nov 2025 08:00:00 GMT
 q3 earnings estimate for amlx issued by lifesci capital  MarketBeat Thu, 30 Oct 2025 12:39:57 GMT

Amylyx Pharmaceuticals, Inc.
(NASDAQ:AMLX) 

AMLX stock logo

Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taur...

Founded: 2013
IPO Price: $19 (Jan 07, 2022)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends